NU-1223

NU-1223 is an experimental drug from the β-carboline family, which is thought to act as a selective agonist of the 5-HT_2C receptor. It has been investigated for possible applications in the treatment of schizophrenia.^[1]

NU-1223

Identifiers
IUPAC name 1-pyrimidin-5-yl-9H-pyrido[3,4-b]indol-6-ol
CAS Number	2415092-49-6
PubChem CID	146464666
Chemical and physical data
Formula	C15H10N4O
Molar mass	262.272 g·mol−1
3D model (JSmol)	Interactive image
SMILES C1=CC2=C(C=C1O)C3=C(N2)C(=NC=C3)C4=CN=CN=C4
InChI InChI=1S/C15H10N4O/c20-10-1-2-13-12(5-10)11-3-4-18-14(15(11)19-13)9-6-16-8-17-7-9/h1-8,19-20H Key:QIMOFNWSIPJEKQ-UHFFFAOYSA-N

See also

• Substituted β-carboline
• Alstonine
• Harmine
• LY-272,015
• Fenharmane